193 related articles for article (PubMed ID: 27895483)
21. Robust IgG responses to nanograms of antigen using a biomimetic lipid-coated particle vaccine.
Bershteyn A; Hanson MC; Crespo MP; Moon JJ; Li AV; Suh H; Irvine DJ
J Control Release; 2012 Feb; 157(3):354-65. PubMed ID: 21820024
[TBL] [Abstract][Full Text] [Related]
22. Delivering all in one: Antigen-nanocapsule loaded with dual adjuvant yields superadditive effects by DC-directed T cell stimulation.
Paßlick D; Piradashvili K; Bamberger D; Li M; Jiang S; Strand D; R Wich P; Landfester K; Bros M; Grabbe S; Mailänder V
J Control Release; 2018 Nov; 289():23-34. PubMed ID: 30219277
[TBL] [Abstract][Full Text] [Related]
23. B subunit of Shiga toxin-based vaccines synergize with alpha-galactosylceramide to break tolerance against self antigen and elicit antiviral immunity.
Adotevi O; Vingert B; Freyburger L; Shrikant P; Lone YC; Quintin-Colonna F; Haicheur N; Amessou M; Herbelin A; Langlade-Demoyen P; Fridman WH; Lemonnier F; Johannes L; Tartour E
J Immunol; 2007 Sep; 179(5):3371-9. PubMed ID: 17709554
[TBL] [Abstract][Full Text] [Related]
24. Surface modification of poly(D,L-lactic-co-glycolic acid) nanoparticles with protamine enhanced cross-presentation of encapsulated ovalbumin by bone marrow-derived dendritic cells.
Han R; Zhu J; Yang X; Xu H
J Biomed Mater Res A; 2011 Jan; 96(1):142-9. PubMed ID: 21105162
[TBL] [Abstract][Full Text] [Related]
25. Immune responses to vaccines delivered by encapsulation into and/or adsorption onto cationic lipid-PLGA hybrid nanoparticles.
Liu L; Ma P; Wang H; Zhang C; Sun H; Wang C; Song C; Leng X; Kong D; Ma G
J Control Release; 2016 Mar; 225():230-9. PubMed ID: 26826307
[TBL] [Abstract][Full Text] [Related]
26. Immunopotentiator-Loaded Polymeric Microparticles as Robust Adjuvant to Improve Vaccine Efficacy.
Zhang W; Wang L; Yang T; Liu Y; Chen X; Liu Q; Jia J; Ma G
Pharm Res; 2015 Sep; 32(9):2837-50. PubMed ID: 26017300
[TBL] [Abstract][Full Text] [Related]
27. pH Sensitive phosphorylated chitosan hydrogel as vaccine delivery system for intramuscular immunization.
Wei J; Xue W; Yu X; Qiu X; Liu Z
J Biomater Appl; 2017 May; 31(10):1358-1369. PubMed ID: 28387574
[TBL] [Abstract][Full Text] [Related]
28. Intradermal vaccination with hollow microneedles: A comparative study of various protein antigen and adjuvant encapsulated nanoparticles.
Du G; Hathout RM; Nasr M; Nejadnik MR; Tu J; Koning RI; Koster AJ; Slütter B; Kros A; Jiskoot W; Bouwstra JA; Mönkäre J
J Control Release; 2017 Nov; 266():109-118. PubMed ID: 28943194
[TBL] [Abstract][Full Text] [Related]
29. Inverse micellar sugar glass (IMSG) nanoparticles for transfollicular vaccination.
Mittal A; Schulze K; Ebensen T; Weissmann S; Hansen S; Guzmán CA; Lehr CM
J Control Release; 2015 May; 206():140-52. PubMed ID: 25795506
[TBL] [Abstract][Full Text] [Related]
30. A visible fluorescent nanovaccine based on functional genipin crosslinked ovalbumin protein nanoparticles.
Dong X; Sun Z; Liang J; Wang H; Zhu D; Leng X; Wang C; Kong D; Lv F
Nanomedicine; 2018 Jun; 14(4):1087-1098. PubMed ID: 29474923
[TBL] [Abstract][Full Text] [Related]
31. Diaminosulfide based polymer microparticles as cancer vaccine delivery systems.
Geary SM; Hu Q; Joshi VB; Bowden NB; Salem AK
J Control Release; 2015 Dec; 220(Pt B):682-90. PubMed ID: 26359124
[TBL] [Abstract][Full Text] [Related]
32. Poly(gamma-glutamic acid) nanoparticles as an efficient antigen delivery and adjuvant system: potential for an AIDS vaccine.
Wang X; Uto T; Akagi T; Akashi M; Baba M
J Med Virol; 2008 Jan; 80(1):11-9. PubMed ID: 18041033
[TBL] [Abstract][Full Text] [Related]
33. Erythrocyte Membrane-Enveloped Polymeric Nanoparticles as Nanovaccine for Induction of Antitumor Immunity against Melanoma.
Guo Y; Wang D; Song Q; Wu T; Zhuang X; Bao Y; Kong M; Qi Y; Tan S; Zhang Z
ACS Nano; 2015 Jul; 9(7):6918-33. PubMed ID: 26153897
[TBL] [Abstract][Full Text] [Related]
34. Hollow microneedle-mediated intradermal delivery of model vaccine antigen-loaded PLGA nanoparticles elicits protective T cell-mediated immunity to an intracellular bacterium.
de Groot AM; Du G; Mönkäre J; Platteel ACM; Broere F; Bouwstra JA; Sijts AJAM
J Control Release; 2017 Nov; 266():27-35. PubMed ID: 28917531
[TBL] [Abstract][Full Text] [Related]
35. Encapsulation of antigen in poly(D,L-lactide-co-glycolide) microspheres protects from harmful effects of γ-irradiation as assessed in mice.
Mohanan D; Gander B; Kündig TM; Johansen P
Eur J Pharm Biopharm; 2012 Feb; 80(2):274-81. PubMed ID: 22024408
[TBL] [Abstract][Full Text] [Related]
36. Polyanhydride nanovaccine against swine influenza virus in pigs.
Dhakal S; Goodman J; Bondra K; Lakshmanappa YS; Hiremath J; Shyu DL; Ouyang K; Kang KI; Krakowka S; Wannemuehler MJ; Won Lee C; Narasimhan B; Renukaradhya GJ
Vaccine; 2017 Feb; 35(8):1124-1131. PubMed ID: 28117173
[TBL] [Abstract][Full Text] [Related]
37. CD40-targeted dendritic cell delivery of PLGA-nanoparticle vaccines induce potent anti-tumor responses.
Rosalia RA; Cruz LJ; van Duikeren S; Tromp AT; Silva AL; Jiskoot W; de Gruijl T; Löwik C; Oostendorp J; van der Burg SH; Ossendorp F
Biomaterials; 2015 Feb; 40():88-97. PubMed ID: 25465442
[TBL] [Abstract][Full Text] [Related]
38. Nanovaccine Incorporated with Hydroxychloroquine Enhances Antigen Cross-Presentation and Promotes Antitumor Immune Responses.
Liu J; Liu X; Han Y; Zhang J; Liu D; Ma G; Li C; Liu L; Kong D
ACS Appl Mater Interfaces; 2018 Sep; 10(37):30983-30993. PubMed ID: 30136844
[TBL] [Abstract][Full Text] [Related]
39. A trifunctional dextran-based nanovaccine targets and activates murine dendritic cells, and induces potent cellular and humoral immune responses in vivo.
Shen L; Higuchi T; Tubbe I; Voltz N; Krummen M; Pektor S; Montermann E; Rausch K; Schmidt M; Schild H; Grabbe S; Bros M
PLoS One; 2013; 8(12):e80904. PubMed ID: 24339889
[TBL] [Abstract][Full Text] [Related]
40. Simple nanoliposomes encapsulating
Bo R; Sun Y; Zhou S; Ou N; Gu P; Liu Z; Hu Y; Liu J; Wang D
Int J Nanomedicine; 2017; 12():6289-6301. PubMed ID: 28894367
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]